Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Sample handling for mass spectrometric proteomic investigations of human urine.

Petri AL, Høgdall C, Christensen IJ, Simonsen AH, T'jampens D, Hellmann ML, Kjaer SK, Fung ET, Høgdall E.

Proteomics Clin Appl. 2008 Sep;2(9):1184-93. doi: 10.1002/prca.200780010. Epub 2008 Jul 21.

PMID:
21136916
2.

Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.

Papale M, Pedicillo MC, Thatcher BJ, Di Paolo S, Lo Muzio L, Bufo P, Rocchetti MT, Centra M, Ranieri E, Gesualdo L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):205-13. Epub 2007 Jun 12.

PMID:
17613287
3.

Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry.

Roelofsen H, Alvarez-Llamas G, Schepers M, Landman K, Vonk RJ.

Proteome Sci. 2007 Jan 15;5:2.

4.

Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads.

Deng B, Dong Z, Liu Y, Wang C, Liu J, Wang C, Qu X.

Clin Chim Acta. 2010 Aug 5;411(15-16):1051-7. doi: 10.1016/j.cca.2010.03.036. Epub 2010 Mar 31.

PMID:
20361951
5.

Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.

Calvano CD, Aresta A, Iacovone M, De Benedetto GE, Zambonin CG, Battaglia M, Ditonno P, Rutigliano M, Bettocchi C.

J Pharm Biomed Anal. 2010 Mar 11;51(4):907-14. doi: 10.1016/j.jpba.2009.10.014. Epub 2009 Oct 30.

PMID:
19939598
6.

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.

Simonsen AH, Bahl JM, Danborg PB, Lindstrom V, Larsen SO, Grubb A, Heegaard NH, Waldemar G.

J Neurosci Methods. 2013 May 15;215(2):234-40. doi: 10.1016/j.jneumeth.2013.03.011. Epub 2013 Mar 26.

PMID:
23537933
7.

Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, Ceglarek U.

Clin Chem. 2007 Mar;53(3):421-8. Epub 2007 Feb 1.

9.

SELDI-TOF-MS of saliva: methodology and pre-treatment effects.

Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):45-53. Epub 2006 Oct 27.

PMID:
17070117
10.

Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.

Timms JF, Arslan-Low E, Gentry-Maharaj A, Luo Z, T'Jampens D, Podust VN, Ford J, Fung ET, Gammerman A, Jacobs I, Menon U.

Clin Chem. 2007 Apr;53(4):645-56. Epub 2007 Feb 15.

11.

Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.

Kemna EH, Tjalsma H, Podust VN, Swinkels DW.

Clin Chem. 2007 Apr;53(4):620-8. Epub 2007 Feb 1.

12.

Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis.

Papale M, Pedicillo MC, Di Paolo S, Thatcher BJ, Lo Muzio L, Bufo P, Rocchetti MT, Centra M, Ranieri E, Gesualdo L.

Clin Chem Lab Med. 2008;46(1):89-99.

PMID:
18020972
13.

Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.

Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Mori K, Yamaya K, Ohyama C.

Oncol Rep. 2009 Jan;21(1):73-9.

PMID:
19082445
14.

Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.

Geng T, Seitz PK, Thomas ML, Xu B, Soman KV, Kurosky A, Luxon BA, Cunningham KA.

J Neurosci Methods. 2006 Nov 15;158(1):1-12.

PMID:
16766040
15.

Sample handling for mass spectrometric proteomic investigations of human sera.

West-Nielsen M, Høgdall EV, Marchiori E, Høgdall CK, Schou C, Heegaard NH.

Anal Chem. 2005 Aug 15;77(16):5114-23.

PMID:
16097747
16.

Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).

O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS.

Clin Invest Med. 2006 Jun;29(3):136-45.

PMID:
17058431
17.

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA.

Clin Chem. 2005 Jan;51(1):189-95. Epub 2004 Nov 11.

18.

The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).

Rosenling T, Slim CL, Christin C, Coulier L, Shi S, Stoop MP, Bosman J, Suits F, Horvatovich PL, Stockhofe-Zurwieden N, Vreeken R, Hankemeier T, van Gool AJ, Luider TM, Bischoff R.

J Proteome Res. 2009 Dec;8(12):5511-22. doi: 10.1021/pr9005876.

PMID:
19845411
19.

Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P.

Kidney Int. 2004 Jan;65(1):323-32.

Supplemental Content

Support Center